A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
Nerviano Medical Sciences
Roswell Park Cancer Institute
NextCure, Inc.
Novartis
Dana-Farber Cancer Institute
Montefiore Medical Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
M.D. Anderson Cancer Center
Thomas Jefferson University
Takeda
Amgen
Roswell Park Cancer Institute
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Thomas Jefferson University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fujifilm Pharmaceuticals U.S.A., Inc.
Stemline Therapeutics, Inc.
Takeda
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc.
Kura Oncology, Inc.
IGF Oncology, LLC
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Pfizer
Pfizer
Stanford University
Sumitomo Pharma America, Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Albert Einstein College of Medicine
Eastern Cooperative Oncology Group
Rutgers, The State University of New Jersey
Fred Hutchinson Cancer Center
GlaxoSmithKline
Fred Hutchinson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Merck Sharp & Dohme LLC
H. Lee Moffitt Cancer Center and Research Institute